Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × abemaciclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Ovarian Neoplasms 4 Neoplasms 4 Triple Negative Breast Neoplasms 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Glioblastoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms, Male 2 Breast Diseases 2 Unilateral Breast Neoplasms 1 Solid Tumor, Adult 1 Sarcoma, Kaposi 1 Retinoblastoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms by Site 1 Neoplasm, Residual 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Hematologic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 5 Specimen Handling 4 Proton Therapy 3 Everolimus 3 pembrolizumab 2 gallium Ga 68 dotatate 2 Sunitinib 2 Radiosurgery 2 Protons 2 Observation 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Elasticity Imaging Techniques 2 Bevacizumab 2 trametinib 1 regorafenib 1 olaparib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 cabozantinib 1 auricularum 1 apatinib 1 abemaciclib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

St. Joseph's Hospital and Medical Center, Phoenix

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡